Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressionsYong-Chen Lu, Xin Yao, Jessica S Crystal, et al.Medical Care|December 22, 1999
The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United StatesW E Cunningham, R M Andersen, M H Katz, et al.The American Journal of Medicine|August 5, 2000
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization StudyR D Hays, W E Cunningham, C D Sherbourne, et al.Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.HIV Medicine|March 30, 2019
Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort studyK So-Armah, S K Gupta, S Kundu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast CancerYasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.Pageof 12